2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone

C135H184ClN9O25S9 — CID 160938380

IUPAC2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone
SMILESCC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(C3=NNNN3C)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(C)(=O)=O)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2nnc(-c3ccccc3)s2)CC1.Cc1c(CC(=O)C2CCC(CS(=O)(=O)C(C)C)CC2)ccc2oc(=O)ccc12.Cc1cc(N2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1CC(=O)C1CCC(CS(=O)(=O)C(C)C)CC1
InChIInChI=1S/C30H40ClNO4S.C24H31NO5S2.C22H28O5S.C20H30N4O3S.C20H26N2O3S2.C19H29NO5S2/c1-21(2)37(35,36)20-23-4-6-24(7-5-23)29(33)19-25-8-13-28(18-22(25)3)32-16-14-30(34,15-17-32)26-9-11-27(31)12-10-26;1-18(2)31(27,28)17-20-8-12-21(13-9-20)24(26)16-19-10-14-22(15-11-19)25-32(29,30)23-6-4-3-5-7-23;1-14(2)28(25,26)13-16-4-6-17(7-5-16)20(23)12-18-8-10-21-19(15(18)3)9-11-22(24)27-21;1-14(2)28(26,27)13-16-6-8-17(9-7-16)19(25)12-15-4-10-18(11-5-15)20-21-22-23-24(20)3;1-14(2)27(24,25)13-15-8-10-16(11-9-15)18(23)12-19-21-22-20(26-19)17-6-4-3-5-7-17;1-14(2)27(24,25)13-16-4-8-17(9-5-16)19(21)12-15-6-10-18(11-7-15)20-26(3,22)23/h8-13,18,21,23-24,34H,4-7,14-17,19-20H2,1-3H3;3-7,10-11,14-15,18,20-21,25H,8-9,12-13,16-17H2,1-2H3;8-11,14,16-17H,4-7,12-13H2,1-3H3;4-5,10-11,14,16-17,22-23H,6-9,12-13H2,1-3H3;3-7,14-16H,8-13H2,1-2H3;6-7,10-11,14,16-17,20H,4-5,8-9,12-13H2,1-3H3
InChIKeySUEDMSNVJRJTQH-UHFFFAOYSA-N
MW2657.05 g/mol
LogP22.74
Rot. Bonds45

About 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone

2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone (PubChem CID 160938380) has the molecular formula C135H184ClN9O25S9 and a molecular weight of 2657.05 g/mol. Its IUPAC name is 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone.

Molecular Properties

Compound Name2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone
PubChem CID160938380
Molecular FormulaC135H184ClN9O25S9
Molecular Weight2657.05 g/mol
Exact Mass2654.06
IUPAC Name2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone
SMILESCC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(C3=NNNN3C)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(C)(=O)=O)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2nnc(-c3ccccc3)s2)CC1.Cc1c(CC(=O)C2CCC(CS(=O)(=O)C(C)C)CC2)ccc2oc(=O)ccc12.Cc1cc(N2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1CC(=O)C1CCC(CS(=O)(=O)C(C)C)CC1
InChIInChI=1S/C30H40ClNO4S.C24H31NO5S2.C22H28O5S.C20H30N4O3S.C20H26N2O3S2.C19H29NO5S2/c1-21(2)37(35,36)20-23-4-6-24(7-5-23)29(33)19-25-8-13-28(18-22(25)3)32-16-14-30(34,15-17-32)26-9-11-27(31)12-10-26;1-18(2)31(27,28)17-20-8-12-21(13-9-20)24(26)16-19-10-14-22(15-11-19)25-32(29,30)23-6-4-3-5-7-23;1-14(2)28(25,26)13-16-4-6-17(7-5-16)20(23)12-18-8-10-21-19(15(18)3)9-11-22(24)27-21;1-14(2)28(26,27)13-16-6-8-17(9-7-16)19(25)12-15-4-10-18(11-5-15)20-21-22-23-24(20)3;1-14(2)27(24,25)13-15-8-10-16(11-9-15)18(23)12-19-21-22-20(26-19)17-6-4-3-5-7-17;1-14(2)27(24,25)13-16-4-8-17(9-5-16)19(21)12-15-6-10-18(11-7-15)20-26(3,22)23/h8-13,18,21,23-24,34H,4-7,14-17,19-20H2,1-3H3;3-7,10-11,14-15,18,20-21,25H,8-9,12-13,16-17H2,1-2H3;8-11,14,16-17H,4-7,12-13H2,1-3H3;4-5,10-11,14,16-17,22-23H,6-9,12-13H2,1-3H3;3-7,14-16H,8-13H2,1-2H3;6-7,10-11,14,16-17,20H,4-5,8-9,12-13H2,1-3H3
InChIKeySUEDMSNVJRJTQH-UHFFFAOYSA-N
XLogP22.74
TPSA518.72 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds45
Heavy Atoms179
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002657.05
LogP ≤ 522.74
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'cumarine', 'substructure': 'N/A'}

Analyze 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone?
The IUPAC name of 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone (CID 160938380) is 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone.
What is the SMILES notation for 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone?
The canonical SMILES for 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone is CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(C3=NNNN3C)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2ccc(NS(C)(=O)=O)cc2)CC1.CC(C)S(=O)(=O)CC1CCC(C(=O)Cc2nnc(-c3ccccc3)s2)CC1.Cc1c(CC(=O)C2CCC(CS(=O)(=O)C(C)C)CC2)ccc2oc(=O)ccc12.Cc1cc(N2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1CC(=O)C1CCC(CS(=O)(=O)C(C)C)CC1.
What is the InChIKey of 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone?
The InChIKey is SUEDMSNVJRJTQH-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H40ClNO4S.C24H31NO5S2.C22H28O5S.C20H30N4O3S.C20H26N2O3S2.C19H29NO5S2/c1-21(2)37(35,36)20-23-4-6-24(7-5-23)29(33)19-25-8-13-28(18-22(25)3)32-16-14-30(34,15-17-32)26-9-11-27(31)12-10-26;1-18(2)31(27,28)17-20-8-12-21(13-9-20)24(26)16-19-10-14-22(15-11-19)25-32(29,30)23-6-4-3-5-7-23;1-14(2)28(25,26)13-16-4-6-17(7-5-16)20(23)12-18-8-10-21-19(15(18)3)9-11-22(24)27-21;1-14(2)28(26,27)13-16-6-8-17(9-7-16)19(25)12-15-4-10-18(11-5-15)20-21-22-23-24(20)3;1-14(2)27(24,25)13-15-8-10-16(11-9-15)18(23)12-19-21-22-20(26-19)17-6-4-3-5-7-17;1-14(2)27(24,25)13-16-4-8-17(9-5-16)19(21)12-15-6-10-18(11-7-15)20-26(3,22)23/h8-13,18,21,23-24,34H,4-7,14-17,19-20H2,1-3H3;3-7,10-11,14-15,18,20-21,25H,8-9,12-13,16-17H2,1-2H3;8-11,14,16-17H,4-7,12-13H2,1-3H3;4-5,10-11,14,16-17,22-23H,6-9,12-13H2,1-3H3;3-7,14-16H,8-13H2,1-2H3;6-7,10-11,14,16-17,20H,4-5,8-9,12-13H2,1-3H3.
What are the key properties of 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone?
2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone has a molecular weight of 2657.05 g/mol, XLogP of 22.74, 45 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2-methylphenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;2-[4-(1-methyl-2,3-dihydrotetrazol-5-yl)phenyl]-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone;5-methyl-6-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]chromen-2-one;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]benzenesulfonamide;N-[4-[2-oxo-2-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethyl]phenyl]methanesulfonamide;2-(5-phenyl-1,3,4-thiadiazol-2-yl)-1-[4-(propan-2-ylsulfonylmethyl)cyclohexyl]ethanone is sourced from PubChem (CID 160938380), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).